Plasma level of the endogenous sodium pump ligand marinobufagenin is related to the salt-sensitivity in men
暂无分享,去创建一个
[1] W. März,et al. Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications , 2015, Clinical and experimental hypertension.
[2] Bradley S. Fleenor,et al. Dietary sodium restriction and association with urinary marinobufagenin, blood pressure, and aortic stiffness. , 2013, Clinical journal of the American Society of Nephrology : CJASN.
[3] J. Shapiro,et al. Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets , 2009, Pharmacological Reviews.
[4] David E. Anderson,et al. Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[5] A. Askari,et al. Progesterone binding to the α1-subunit of the Na/K-ATPase on the cell surface: Insights from computational modeling , 2008, Steroids.
[6] O. Melander,et al. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma , 2007, Journal of hypertension.
[7] E. Lakatta,et al. Endogenous Ligand of &agr;1 Sodium Pump, Marinobufagenin, Is a Novel Mediator of Sodium Chloride–Dependent Hypertension , 2002, Circulation.
[8] E. Lakatta,et al. Phorbol Diacetate Potentiates Na+-K+ ATPase Inhibition by a Putative Endogenous Ligand, Marinobufagenin , 2002, Hypertension.
[9] G. Bray,et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. , 2001, The New England journal of medicine.
[10] E. Lakatta,et al. Endogenous Na,K Pump Ligands Are Differentially Regulated During Acute NaCl Loading of Dahl Rats , 2000, Circulation.
[11] Orton,et al. EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET , 2000 .
[12] O. Fedorova,et al. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. , 1999, Journal of hypertension.
[13] N. Schork,et al. The alpha1 Na,K-ATPase gene is a susceptibility hypertension gene in the Dahl salt-sensitiveHSD rat. , 1998, The Journal of clinical investigation.
[14] N. Vaziri,et al. Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. , 1998, Clinical and experimental hypertension.
[15] W. Howald,et al. Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction. , 1998, Hypertension.
[16] O. Fedorova,et al. Inhibition of Na/K ATPase From Rat Aorta by Two Na/K Pump Inhibitors, Ouabain and Marinobufagenin: Evidence of Interaction With Different α-Subunit Isoforms , 1997 .
[17] O. Fedorova,et al. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms. , 1997, American journal of hypertension.
[18] A. Logan,et al. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. , 1996, JAMA.
[19] U. Hopfer,et al. Pathophysiological consequences of changes in the coupling ratio of Na,K-ATPase for renal sodium reabsorption and its implications for hypertension. , 1996, Hypertension.
[20] A. Seguro,et al. Effect of low and high potassium diets on H(+)-K(+)-ATPase and Na(+)-K(+)-ATPase activities in the rat inner medullary collecting duct cells. , 1994, Renal physiology and biochemistry.
[21] S. Mujais,et al. Regulation of the renal Na:K pump: role of progesterone. , 1993, Journal of the American Society of Nephrology : JASN.
[22] Y. Yamori,et al. POTASSIUM ACCELERATES URINARY SODIUM EXCRETION DURING SALT LOADING WITHOUT STIMULATING ATRIAL NATRIURETIC POLYPEPTIDE SECRETION , 1992, Clinical and experimental pharmacology & physiology.
[23] L. Svetkey,et al. Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension. , 1992, Journal of the American Society of Nephrology : JASN.
[24] N. Fineberg,et al. Sodium and Volume Sensitivity of Blood Pressure Age and Pressure Change Over Time , 1991, Hypertension.
[25] M. A. Clark,et al. Purification of an Endogenous Digitalislike Factor From Human Plasma for Structural Analysis , 1991, Hypertension.
[26] N. Fineberg,et al. Definitions and Characteristics of Sodium Sensitivity and Blood Pressure Resistance , 1986, Hypertension.
[27] N. Markandu,et al. MODERATE POTASSIUM SUPPLEMENTATION IN ESSENTIAL HYPERTENSION , 1982, The Lancet.
[28] M. Blaustein. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. , 1977, The American journal of physiology.
[29] H. W. Overbeck,et al. The role of humoral agents in volume expanded hypertension. , 1976, Life sciences.
[30] J. Iwai,et al. Humoral transmission of hypertension: evidence from parabiosis. , 1969, Circulation research.
[31] Cole Lb,et al. An attack of tetanus. , 1968 .